August 06, 2020
Veracyte, Inc. has announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of US$30.00 per share. The gross proceeds to the Company from this offering, before deducting underwriting discounts and commissions and offering expenses payable by Veracyte, are expected to be US$180.0 million. All of the shares are being offered by the Company. In addition, the Company granted to the underwriters participating in the offering a 30-day option to purchase up to an additional 900,000 shares of its common stock at the public offering price, less underwriting discounts and commissions.
Latham & Watkins LLP represents the underwriters in the offering with a capital markets team led by partners Peter Handrinos and Wesley Holmes, with associates Anthony Gostanian, Denis Griffin and Briana Goncalves.